United States · Markets & Finance · Yahoo Finance

AnnJi Pharmaceutical Advances AJ201 into Pivotal Phase 3 ROMA-KD Trial for Spinal and Bulbar Muscular Atrophy (SBMA)

Published by Yahoo Finance · United States 10 h ago

AnnJi Pharmaceutical Co., Ltd. (AnnJi, TPEx: 7754), a clinical-stage drug development company focused on innovative small molecules, today announced that it is proceeding with the…

Read the full article on Yahoo Finance Sign in to save

MediaNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (finance.yahoo.com)

Also worth reading

Seeking Alpha

Japan’s PMI data signals cooling momentum across manufacturing and services

CoinDesk

Joint venture of OKX and NYSE parent ICE files for 24/7 tokenized U.S. stock trading

CNBC

Russia hospitalizes almost 200 people after researcher's death from plague: reports

Business Insider

After 11 years on an H-1B visa, I still miss my family back home. Here’s why I stay in the US.

Cointelegraph

Zcash activates NU7 on testnet ahead of November mainnet target

Quartz